Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New Safety Aspects in Corneal Donation-Studies on SARS-CoV-2-Positive Corneal Donors.
Wille D, Heinzelmann J, Kehlen A, Lütgehetmann M, Nörz DS, Siebolts U, Mueller A, Karrasch M, Hofmann N, Viestenz A, Börgel M, Kuhn F, Viestenz A. Wille D, et al. Among authors: karrasch m. J Clin Med. 2022 Jun 9;11(12):3312. doi: 10.3390/jcm11123312. J Clin Med. 2022. PMID: 35743381 Free PMC article.
Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease.
Snellman A, Ekblad LL, Ashton NJ, Karikari TK, Lantero-Rodriguez J, Pietilä E, Koivumäki M, Helin S, Karrasch M, Zetterberg H, Blennow K, Rinne JO. Snellman A, et al. Among authors: karrasch m. Neurobiol Dis. 2023 Jul;183:106175. doi: 10.1016/j.nbd.2023.106175. Epub 2023 Jun 1. Neurobiol Dis. 2023. PMID: 37268240 Free article.
APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
Snellman A, Ekblad LL, Tuisku J, Koivumäki M, Ashton NJ, Lantero-Rodriguez J, Karikari TK, Helin S, Bucci M, Löyttyniemi E, Parkkola R, Karrasch M, Schöll M, Zetterberg H, Blennow K, Rinne JO. Snellman A, et al. Among authors: karrasch m. Alzheimers Res Ther. 2023 Apr 4;15(1):71. doi: 10.1186/s13195-023-01209-6. Alzheimers Res Ther. 2023. PMID: 37016464 Free PMC article.
Cognitive Performance at Time of AD Diagnosis: A Clinically Augmented Register-Based Study.
Alenius M, Hokkanen L, Koskinen S, Hallikainen I, Hänninen T, Karrasch M, Raivio MM, Laakkonen ML, Krüger J, Suhonen NM, Kivipelto M, Ngandu T. Alenius M, et al. Among authors: karrasch m. Front Psychol. 2022 Jul 1;13:901945. doi: 10.3389/fpsyg.2022.901945. eCollection 2022. Front Psychol. 2022. PMID: 35846684 Free PMC article.
ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline Characteristics.
Snellman A, Ekblad LL, Koivumäki M, Lindgrén N, Tuisku J, Perälä M, Kallio L, Lehtonen R, Saunavaara V, Saunavaara J, Oikonen V, Aarnio R, Löyttyniemi E, Parkkola R, Karrasch M, Zetterberg H, Blennow K, Rinne JO. Snellman A, et al. Among authors: karrasch m. Front Neurol. 2022 Feb 9;13:826423. doi: 10.3389/fneur.2022.826423. eCollection 2022. Front Neurol. 2022. PMID: 35222254 Free PMC article.
Education-Based Cutoffs for Cognitive Screening of Alzheimer's Disease.
Alenius M, Ngandu T, Koskinen S, Hallikainen I, Hänninen T, Karrasch M, Kivipelto M, Raivio MM, Laakkonen ML, Krüger J, Suhonen NM, Hokkanen L. Alenius M, et al. Among authors: karrasch m. Dement Geriatr Cogn Disord. 2022;51(1):42-55. doi: 10.1159/000521982. Epub 2022 Feb 23. Dement Geriatr Cogn Disord. 2022. PMID: 35196653
99 results